Ligne de temps
Timothée Bruel
Chef(fe) de Groupe
26 sept. 2024
publication
Levels and functionality of Pacific Islanders’ hybrid humoral immune response to BNT162b2 vaccination and delta/omicron infection: A cohort study in New Caledonia.
Lire plus19 juil. 2024
publication
Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2.
Lire plus13 déc. 2023
14 juin 2023
publication
Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals.
Lire plus01 juin 2023
publication
Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021.
Lire plus14 févr. 2023
publication
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies.
Lire plus24 janv. 2023
17 nov. 2022
publication
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies.
Lire plus05 oct. 2022
publication
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection.
Lire plus01 sept. 2022
publication
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.
Lire plus27 août 2022
08 juil. 2022
publication
Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination.
Lire plus04 juil. 2022
publication
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
Lire plus17 juin 2022
news
New publication – Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2
Lire plus01 juin 2022
publication
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies.
Lire plus04 mai 2022
publication
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen.
Lire plus12 mars 2022
publication
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2.
Lire plus02 févr. 2022
publication
Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells.
Lire plus01 févr. 2022
01 janv. 2022
publication
Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.
Lire plus01 nov. 2021
publication
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study.
Lire plus17 sept. 2021
publication
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2.
Lire plus01 sept. 2021
publication
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.
Lire plus18 août 2021
01 août 2021
publication
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.
Lire plus22 juil. 2021
news
SARS-CoV-2 : induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance
Lire plus08 juil. 2021
08 juin 2021
news
Covid-19, un an après : persistance des anticorps protecteurs et réduction significative du risque de réinfection
Lire plus18 mai 2021
publication
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.
Lire plus01 avr. 2021
publication
SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020
Lire plus01 janv. 2021
01 déc. 2020
02 sept. 2020
publication
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
Lire plus01 sept. 2020
publication
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France.
Lire plus05 févr. 2020
publication
Anti-HIV-1 antibodies trigger non-lytic complement deposition on infected cells.
Lire plus15 oct. 2019
01 juin 2019
publication
Accelerated thymopoiesis and improved T-cell responses in HLA-A2/-DR2 transgenic BRGS-based human immune system mice.
Lire plus01 août 2018
23 févr. 2018
publication
Correction: Stage-specific IFN-induced and IFN gene expression reveal convergence of type I and type II IFN and highlight their role in both acute and chronic stage of pathogenic SIV infection.
Lire plus13 oct. 2017
publication
HIV Fusion in Dendritic Cells Occurs Mainly at the Surface and Is Limited by Low CD4 Levels
Lire plus14 juin 2017
publication
Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells.
Lire plus01 mai 2017
15 mars 2017
publication
Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.
Lire plus15 mars 2017
publication
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses
Lire plus25 janv. 2017
10 oct. 2016
publication
CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challenge
Lire plus12 sept. 2016
03 mars 2016
03 mars 2016
01 janv. 2016
publication
Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles.
Lire plus01 juil. 2015
11 mai 2015
14 janv. 2015
publication
Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses
Lire plus26 nov. 2014
30 janv. 2014
publication
Plasmacytoid dendritic cell dynamics tune interferon-alfa production in SIV-infected cynomolgus macaques
Lire plus12 janv. 2012
publication
Porcine colon explants in the study of innate immune response to Entamoeba histolytica
Lire plus21 déc. 2011
13 avr. 2010
publication
Expression and immunogenicity of the mycobacterial Ag85B/ESAT-6 antigens produced in transgenic plants by elastin-like peptide fusion strategy
Lire plus06 janv. 2010
publication